Global Valsartan Market Growth 2021-2026

Publisher Name :
Date: 03-May-2021
No. of pages: 110

According to this latest study, the 2021 growth of Valsartan will have significant change from previous year. By the most conservative estimates of global Valsartan market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Valsartan market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Valsartan market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

- 40 mg Tablets

- 80 mg Tablets

- 160 mg Tablets

- 320 mg Tablets

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

- Hypertension

- Heart Failure

- Heart Attack

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

- Novartis

- Sun Pharmaceutical

- Teva

- Mylan

- Alembic Pharmaceuticals

- Lupin

- Aurobindo Pharma

- Macleods Pharmaceuticals

- HETERO

- Torrent Pharmaceuticals

- Huaren Pharmaceutical

- Jubilant Pharma

- Amneal Pharmaceuticals

- Zhejiang Huahai Pharmaceutical

- Square Pharmaceuticals

- Unichem Laboratories

- LG Life Sciences

Global Valsartan Market Growth 2021-2026

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Valsartan Consumption 2016-2026
2.1.2 Valsartan Consumption CAGR by Region
2.2 Valsartan Segment by Type
2.2.1 40 mg Tablets
2.2.2 80 mg Tablets
2.2.3 160 mg Tablets
2.2.4 320 mg Tablets
2.3 Valsartan Sales by Type
2.3.1 Global Valsartan Sales Market Share by Type (2016-2021)
2.3.2 Global Valsartan Revenue and Market Share by Type (2016-2021)
2.3.3 Global Valsartan Sale Price by Type (2016-2021)
2.4 Valsartan Segment by Application
2.4.1 Hypertension
2.4.2 Heart Failure
2.4.3 Heart Attack
2.5 Valsartan Sales by Application
2.5.1 Global Valsartan Sale Market Share by Application (2016-2021)
2.5.2 Global Valsartan Revenue and Market Share by Application (2016-2021)
2.5.3 Global Valsartan Sale Price by Application (2016-2021)

3 Global Valsartan by Company
3.1 Global Valsartan Sales Market Share by Company
3.1.1 Global Valsartan Sales by Company (2019-2021)
3.1.2 Global Valsartan Sales Market Share by Company (2019-2021)
3.2 Global Valsartan Revenue Market Share by Company
3.2.1 Global Valsartan Revenue by Company (2019-2021)
3.2.2 Global Valsartan Revenue Market Share by Company (2019-2021)
3.3 Global Valsartan Sale Price by Company
3.4 Global Manufacturers Valsartan Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Valsartan Product Location Distribution
3.4.2 Players Valsartan Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Valsartan by Region
4.1 Global Valsartan by Region
4.1.1 Global Valsartan Sales by Region
4.1.2 Global Valsartan Revenue by Region
4.2 Americas Valsartan Sales Growth
4.3 APAC Valsartan Sales Growth
4.4 Europe Valsartan Sales Growth
4.5 Middle East & Africa Valsartan Sales Growth

5 Americas
5.1 Americas Valsartan Sales by Country
5.1.1 Americas Valsartan Sales by Country (2016-2021)
5.1.2 Americas Valsartan Revenue by Country (2016-2021)
5.2 Americas Valsartan Sales by Type
5.3 Americas Valsartan Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Valsartan Sales by Region
6.1.1 APAC Valsartan Sales by Region (2016-2021)
6.1.2 APAC Valsartan Revenue by Region (2016-2021)
6.2 APAC Valsartan Sales by Type
6.3 APAC Valsartan Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Valsartan by Country
7.1.1 Europe Valsartan Sales by Country (2016-2021)
7.1.2 Europe Valsartan Revenue by Country (2016-2021)
7.2 Europe Valsartan Sales by Type
7.3 Europe Valsartan Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Valsartan by Country
8.1.1 Middle East & Africa Valsartan Sales by Country (2016-2021)
8.1.2 Middle East & Africa Valsartan Revenue by Country (2016-2021)
8.2 Middle East & Africa Valsartan Sales by Type
8.3 Middle East & Africa Valsartan Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Valsartan Distributors
10.3 Valsartan Customer

11 Global Valsartan Market Forecast
11.1 Global Valsartan Forecast by Region
11.1.1 Global Valsartan Forecast by Regions (2021-2026)
11.2.2 Global Valsartan Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Valsartan Forecast by Type
11.7 Global Valsartan Forecast by Application

12 Key Players Analysis
12.1 Novartis
12.1.1 Novartis Company Information
12.1.2 Novartis Valsartan Product Offered
12.1.3 Novartis Valsartan Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Novartis Main Business Overview
12.1.5 Novartis Latest Developments
12.2 Sun Pharmaceutical
12.2.1 Sun Pharmaceutical Company Information
12.2.2 Sun Pharmaceutical Valsartan Product Offered
12.2.3 Sun Pharmaceutical Valsartan Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Sun Pharmaceutical Main Business Overview
12.2.5 Sun Pharmaceutical Latest Developments
12.3 Teva
12.3.1 Teva Company Information
12.3.2 Teva Valsartan Product Offered
12.3.3 Teva Valsartan Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Teva Main Business Overview
12.3.5 Teva Latest Developments
12.4 Mylan
12.4.1 Mylan Company Information
12.4.2 Mylan Valsartan Product Offered
12.4.3 Mylan Valsartan Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Mylan Main Business Overview
12.4.5 Mylan Latest Developments
12.5 Alembic Pharmaceuticals
12.5.1 Alembic Pharmaceuticals Company Information
12.5.2 Alembic Pharmaceuticals Valsartan Product Offered
12.5.3 Alembic Pharmaceuticals Valsartan Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Alembic Pharmaceuticals Main Business Overview
12.5.5 Alembic Pharmaceuticals Latest Developments
12.6 Lupin
12.6.1 Lupin Company Information
12.6.2 Lupin Valsartan Product Offered
12.6.3 Lupin Valsartan Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Lupin Main Business Overview
12.6.5 Lupin Latest Developments
12.7 Aurobindo Pharma
12.7.1 Aurobindo Pharma Company Information
12.7.2 Aurobindo Pharma Valsartan Product Offered
12.7.3 Aurobindo Pharma Valsartan Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Aurobindo Pharma Main Business Overview
12.7.5 Aurobindo Pharma Latest Developments
12.8 Macleods Pharmaceuticals
12.8.1 Macleods Pharmaceuticals Company Information
12.8.2 Macleods Pharmaceuticals Valsartan Product Offered
12.8.3 Macleods Pharmaceuticals Valsartan Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Macleods Pharmaceuticals Main Business Overview
12.8.5 Macleods Pharmaceuticals Latest Developments
12.9 HETERO
12.9.1 HETERO Company Information
12.9.2 HETERO Valsartan Product Offered
12.9.3 HETERO Valsartan Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 HETERO Main Business Overview
12.9.5 HETERO Latest Developments
12.10 Torrent Pharmaceuticals
12.10.1 Torrent Pharmaceuticals Company Information
12.10.2 Torrent Pharmaceuticals Valsartan Product Offered
12.10.3 Torrent Pharmaceuticals Valsartan Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Torrent Pharmaceuticals Main Business Overview
12.10.5 Torrent Pharmaceuticals Latest Developments
12.11 Huaren Pharmaceutical
12.11.1 Huaren Pharmaceutical Company Information
12.11.2 Huaren Pharmaceutical Valsartan Product Offered
12.11.3 Huaren Pharmaceutical Valsartan Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Huaren Pharmaceutical Main Business Overview
12.11.5 Huaren Pharmaceutical Latest Developments
12.12 Jubilant Pharma
12.12.1 Jubilant Pharma Company Information
12.12.2 Jubilant Pharma Valsartan Product Offered
12.12.3 Jubilant Pharma Valsartan Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Jubilant Pharma Main Business Overview
12.12.5 Jubilant Pharma Latest Developments
12.13 Amneal Pharmaceuticals
12.13.1 Amneal Pharmaceuticals Company Information
12.13.2 Amneal Pharmaceuticals Valsartan Product Offered
12.13.3 Amneal Pharmaceuticals Valsartan Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Amneal Pharmaceuticals Main Business Overview
12.13.5 Amneal Pharmaceuticals Latest Developments
12.14 Zhejiang Huahai Pharmaceutical
12.14.1 Zhejiang Huahai Pharmaceutical Company Information
12.14.2 Zhejiang Huahai Pharmaceutical Valsartan Product Offered
12.14.3 Zhejiang Huahai Pharmaceutical Valsartan Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Zhejiang Huahai Pharmaceutical Main Business Overview
12.14.5 Zhejiang Huahai Pharmaceutical Latest Developments
12.15 Square Pharmaceuticals
12.15.1 Square Pharmaceuticals Company Information
12.15.2 Square Pharmaceuticals Valsartan Product Offered
12.15.3 Square Pharmaceuticals Valsartan Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Square Pharmaceuticals Main Business Overview
12.15.5 Square Pharmaceuticals Latest Developments
12.16 Unichem Laboratories
12.16.1 Unichem Laboratories Company Information
12.16.2 Unichem Laboratories Valsartan Product Offered
12.16.3 Unichem Laboratories Valsartan Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Unichem Laboratories Main Business Overview
12.16.5 Unichem Laboratories Latest Developments
12.17 LG Life Sciences
12.17.1 LG Life Sciences Company Information
12.17.2 LG Life Sciences Valsartan Product Offered
12.17.3 LG Life Sciences Valsartan Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 LG Life Sciences Main Business Overview
12.17.5 LG Life Sciences Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Valsartan Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of 40 mg Tablets
Table 3. Major Players of 80 mg Tablets
Table 4. Major Players of 160 mg Tablets
Table 5. Major Players of 320 mg Tablets
Table 6. Global Valsartan Sales by Type (2016-2021) & (K Units)
Table 7. Global Valsartan Sales Market Share by Type (2016-2021)
Table 8. Global Valsartan Revenue by Type (2016-2021) & ($ million)
Table 9. Global Valsartan Revenue Market Share by Type (2016-2021)
Table 10. Global Valsartan Sale Price by Type (2016-2021)
Table 11. Global Valsartan Sales by Application (2016-2021) & (K Units)
Table 12. Global Valsartan Sales Market Share by Application (2016-2021)
Table 13. Global Valsartan Value by Application (2016-2021)
Table 14. Global Valsartan Revenue Market Share by Application (2016-2021)
Table 15. Global Valsartan Sale Price by Application (2016-2021)
Table 16. Global Valsartan Sales by Company (2019-2021) & (K Units)
Table 17. Global Valsartan Sales Market Share by Company (2019-2021)
Table 18. Global Valsartan Revenue by Company (2019-2021) ($ Millions)
Table 19. Global Valsartan Revenue Market Share by Company (2019-2021)
Table 20. Global Valsartan Sale Price by Company (2019-2021)
Table 21. Key Manufacturers Valsartan Producing Area Distribution and Sales Area
Table 22. Players Valsartan Products Offered
Table 23. Valsartan Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Valsartan Sales by Region (2016-2021) (K Units)
Table 27. Global Valsartan Sales Market Share by Region (2016-2021)
Table 28. Global Valsartan Revenue by Region (2016-2021) & ($ Millions)
Table 29. Global Valsartan Revenue Market Share by Region (2016-2021)
Table 30. Americas Valsartan Sales by Country (2016-2021) & (K Units)
Table 31. Americas Valsartan Sales Market Share by Country (2016-2021)
Table 32. Americas Valsartan Revenue by Country (2016-2021) & ($ Millions)
Table 33. Americas Valsartan Revenue Market Share by Country (2016-2021)
Table 34. Americas Valsartan Sales by Type (2016-2021) & (K Units)
Table 35. Americas Valsartan Sales Market Share by Type (2016-2021)
Table 36. Americas Valsartan Sales by Application (2016-2021) & (K Units)
Table 37. Americas Valsartan Sales Market Share by Application (2016-2021)
Table 38. APAC Valsartan Sales by Region (2016-2021) & (K Units)
Table 39. APAC Valsartan Sales Market Share by Region (2016-2021)
Table 40. APAC Valsartan Revenue by Region (2016-2021) & ($ Millions)
Table 41. APAC Valsartan Revenue Market Share by Region (2016-2021)
Table 42. APAC Valsartan Sales by Type (2016-2021) & (K Units)
Table 43. APAC Valsartan Sales Market Share by Type (2016-2021)
Table 44. APAC Valsartan Sales by Application (2016-2021) & (K Units)
Table 45. APAC Valsartan Sales Market Share by Application (2016-2021)
Table 46. Europe Valsartan Sales by Country (2016-2021) & (K Units)
Table 47. Europe Valsartan Sales Market Share by Country (2016-2021)
Table 48. Europe Valsartan Revenue by Country (2016-2021) & ($ Millions)
Table 49. Europe Valsartan Revenue Market Share by Country (2016-2021)
Table 50. Europe Valsartan Sales by Type (2016-2021) & (K Units)
Table 51. Europe Valsartan Sales Market Share by Type (2016-2021)
Table 52. Europe Valsartan Sales by Application (2016-2021) & (K Units)
Table 53. Europe Valsartan Sales Market Share by Application (2016-2021)
Table 54. Middle East & Africa Valsartan Sales by Country (2016-2021) & (K Units)
Table 55. Middle East & Africa Valsartan Sales Market Share by Country (2016-2021)
Table 56. Middle East & Africa Valsartan Revenue by Country (2016-2021) & ($ Millions)
Table 57. Middle East & Africa Valsartan Revenue Market Share by Country (2016-2021)
Table 58. Middle East & Africa Valsartan Sales by Type (2016-2021) & (K Units)
Table 59. Middle East & Africa Valsartan Sales Market Share by Type (2016-2021)
Table 60. Middle East & Africa Valsartan Sales by Application (2016-2021) & (K Units)
Table 61. Middle East & Africa Valsartan Sales Market Share by Application (2016-2021)
Table 62. Key and Potential Regions of Valsartan
Table 63. Key Application and Potential Industries of Valsartan
Table 64. Key Challenges of Valsartan
Table 65. Key Trends of Valsartan
Table 66. Valsartan Distributors List
Table 67. Valsartan Customer List
Table 68. Global Valsartan Sales Forecast by Region (2021-2026) & (K Units)
Table 69. Global Valsartan Consumption Market Forecast by Region
Table 70. Global Valsartan Revenue Forecast by Region (2021-2026) & ($ millions)
Table 71. Global Valsartan Revenue Market Share Forecast by Region (2021-2026)
Table 72. Americas Valsartan Sales Forecast by Country (2021-2026) & (K Units)
Table 73. Americas Valsartan Revenue Forecast by Country (2021-2026) & ($ millions)
Table 74. APAC Valsartan Sales Forecast by Region (2021-2026) & (K Units)
Table 75. APAC Valsartan Revenue Forecast by Region (2021-2026) & ($ millions)
Table 76. Europe Valsartan Sales Forecast by Country (2021-2026) & (K Units)
Table 77. Europe Valsartan Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Middle East & Africa Valsartan Sales Forecast by Country (2021-2026) & (K Units)
Table 79. Middle East & Africa Valsartan Revenue Forecast by Country (2021-2026) & ($ millions)
Table 80. Global Valsartan Sales Forecast by Type (2021-2026) & (K Units)
Table 81. Global Valsartan Sales Market Share Forecast by Type (2021-2026)
Table 82. Global Valsartan Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 83. Global Valsartan Revenue Market Share Forecast by Type (2021-2026)
Table 84. Global Valsartan Sales Forecast by Application (2021-2026) & (K Units)
Table 85. Global Valsartan Sales Market Share Forecast by Application (2021-2026)
Table 86. Global Valsartan Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 87. Global Valsartan Revenue Market Share Forecast by Application (2021-2026)
Table 88. Novartis Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 89. Novartis Valsartan Product Offered
Table 90. Novartis Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 91. Novartis Main Business
Table 92. Novartis Latest Developments
Table 93. Sun Pharmaceutical Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 94. Sun Pharmaceutical Valsartan Product Offered
Table 95. Sun Pharmaceutical Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 96. Sun Pharmaceutical Main Business
Table 97. Sun Pharmaceutical Latest Developments
Table 98. Teva Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 99. Teva Valsartan Product Offered
Table 100. Teva Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 101. Teva Main Business
Table 102. Teva Latest Developments
Table 103. Mylan Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 104. Mylan Valsartan Product Offered
Table 105. Mylan Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 106. Mylan Main Business
Table 107. Mylan Latest Developments
Table 108. Alembic Pharmaceuticals Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 109. Alembic Pharmaceuticals Valsartan Product Offered
Table 110. Alembic Pharmaceuticals Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 111. Alembic Pharmaceuticals Main Business
Table 112. Alembic Pharmaceuticals Latest Developments
Table 113. Lupin Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 114. Lupin Valsartan Product Offered
Table 115. Lupin Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 116. Lupin Main Business
Table 117. Lupin Latest Developments
Table 118. Aurobindo Pharma Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 119. Aurobindo Pharma Valsartan Product Offered
Table 120. Aurobindo Pharma Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 121. Aurobindo Pharma Main Business
Table 122. Aurobindo Pharma Latest Developments
Table 123. Macleods Pharmaceuticals Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 124. Macleods Pharmaceuticals Valsartan Product Offered
Table 125. Macleods Pharmaceuticals Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 126. Macleods Pharmaceuticals Main Business
Table 127. Macleods Pharmaceuticals Latest Developments
Table 128. HETERO Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 129. HETERO Valsartan Product Offered
Table 130. HETERO Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 131. HETERO Main Business
Table 132. HETERO Latest Developments
Table 133. Torrent Pharmaceuticals Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 134. Torrent Pharmaceuticals Valsartan Product Offered
Table 135. Torrent Pharmaceuticals Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 136. Torrent Pharmaceuticals Main Business
Table 137. Torrent Pharmaceuticals Latest Developments
Table 138. Huaren Pharmaceutical Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 139. Huaren Pharmaceutical Valsartan Product Offered
Table 140. Huaren Pharmaceutical Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 141. Huaren Pharmaceutical Main Business
Table 142. Huaren Pharmaceutical Latest Developments
Table 143. Jubilant Pharma Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 144. Jubilant Pharma Valsartan Product Offered
Table 145. Jubilant Pharma Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 146. Jubilant Pharma Main Business
Table 147. Jubilant Pharma Latest Developments
Table 148. Amneal Pharmaceuticals Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 149. Amneal Pharmaceuticals Valsartan Product Offered
Table 150. Amneal Pharmaceuticals Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 151. Amneal Pharmaceuticals Main Business
Table 152. Amneal Pharmaceuticals Latest Developments
Table 153. Zhejiang Huahai Pharmaceutical Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 154. Zhejiang Huahai Pharmaceutical Valsartan Product Offered
Table 155. Zhejiang Huahai Pharmaceutical Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 156. Zhejiang Huahai Pharmaceutical Main Business
Table 157. Zhejiang Huahai Pharmaceutical Latest Developments
Table 158. Square Pharmaceuticals Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 159. Square Pharmaceuticals Valsartan Product Offered
Table 160. Square Pharmaceuticals Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 161. Square Pharmaceuticals Main Business
Table 162. Square Pharmaceuticals Latest Developments
Table 163. Unichem Laboratories Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 164. Unichem Laboratories Valsartan Product Offered
Table 165. Unichem Laboratories Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 166. Unichem Laboratories Main Business
Table 167. Unichem Laboratories Latest Developments
Table 168. LG Life Sciences Basic Information, Valsartan Manufacturing Base, Sales Area and Its Competitors
Table 169. LG Life Sciences Valsartan Product Offered
Table 170. LG Life Sciences Valsartan Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 171. LG Life Sciences Main Business
Table 172. LG Life Sciences Latest Developments
List of Figures
Figure 1. Picture of Valsartan
Figure 2. Valsartan Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Valsartan Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Valsartan Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Valsartan Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of 40 mg Tablets
Figure 10. Product Picture of 80 mg Tablets
Figure 11. Product Picture of 160 mg Tablets
Figure 12. Product Picture of 320 mg Tablets
Figure 13. Global Valsartan Sales Market Share by Type in 2020
Figure 14. Global Valsartan Revenue Market Share by Type (2016-2021)
Figure 15. Valsartan Consumed in Hypertension
Figure 16. Global Valsartan Market: Hypertension (2016-2021) & (K Units)
Figure 17. Valsartan Consumed in Heart Failure
Figure 18. Global Valsartan Market: Heart Failure (2016-2021) & (K Units)
Figure 19. Valsartan Consumed in Heart Attack
Figure 20. Global Valsartan Market: Heart Attack (2016-2021) & (K Units)
Figure 21. Global Valsartan Sales Market Share by Application (2016-2021)
Figure 22. Global Valsartan Revenue Market Share by Application in 2020
Figure 23. Valsartan Revenue Market by Company in 2020 ($ Million)
Figure 24. Global Valsartan Revenue Market Share by Company in 2020
Figure 25. Global Valsartan Sales Market Share by Regions (2016-2021)
Figure 26. Global Valsartan Revenue Market Share by Region in 2020
Figure 27. Americas Valsartan Sales 2016-2021 (K Units)
Figure 28. Americas Valsartan Revenue 2016-2021 ($ Millions)
Figure 29. APAC Valsartan Sales 2016-2021 (K Units)
Figure 30. APAC Valsartan Revenue 2016-2021 ($ Millions)
Figure 31. Europe Valsartan Sales 2016-2021 (K Units)
Figure 32. Europe Valsartan Revenue 2016-2021 ($ Millions)
Figure 33. Middle East & Africa Valsartan Sales 2016-2021 (K Units)
Figure 34. Middle East & Africa Valsartan Revenue 2016-2021 ($ Millions)
Figure 35. Americas Valsartan Sales Market Share by Country in 2020
Figure 36. Americas Valsartan Revenue Market Share by Country in 2020
Figure 37. Americas Valsartan Sales Market Share by Type in 2020
Figure 38. Americas Valsartan Sales Market Share by Application in 2020
Figure 39. United States Valsartan Revenue Growth 2016-2021 ($ Millions)
Figure 40. Canada Valsartan Revenue Growth 2016-2021 ($ Millions)
Figure 41. Mexico Valsartan Revenue Growth 2016-2021 ($ Millions)
Figure 42. Brazil Valsartan Revenue Growth 2016-2021 ($ Millions)
Figure 43. APAC Valsartan Sales Market Share by Region in 2020
Figure 44. APAC Valsartan Revenue Market Share by Regions in 2020
Figure 45. APAC Valsartan Sales Market Share by Type in 2020
Figure 46. APAC Valsartan Sales Market Share by Application in 2020
Figure 47. China Valsartan Revenue Growth 2016-2021 ($ Millions)
Figure 48. Japan Valsartan Revenue Growth 2016-2021 ($ Millions)
Figure 49. Korea Valsartan Revenue Growth 2016-2021 ($ Millions)
Figure 50. Southeast Asia Valsartan Revenue Growth 2016-2021 ($ Millions)
Figure 51. India Valsartan Revenue Growth 2016-2021 ($ Millions)
Figure 52. Australia Valsartan Revenue Growth 2016-2021 ($ Millions)
Figure 53. Europe Valsartan Sales Market Share by Country in 2020
Figure 54. Europe Valsartan Revenue Market Share by Country in 2020
Figure 55. Europe Valsartan Sales Market Share by Type in 2020
Figure 56. Europe Valsartan Sales Market Share by Application in 2020
Figure 57. Germany Valsartan Revenue Growth 2016-2021 ($ Millions)
Figure 58. France Valsartan Revenue Growth 2016-2021 ($ Millions)
Figure 59. UK Valsartan Revenue Growth 2016-2021 ($ Millions)
Figure 60. Italy Valsartan Revenue Growth 2016-2021 ($ Millions)
Figure 61. Russia Valsartan Revenue Growth 2016-2021 ($ Millions)
Figure 62. Middle East & Africa Valsartan Sales Market Share by Country in 2020
Figure 63. Middle East & Africa Valsartan Revenue Market Share by Country in 2020
Figure 64. Middle East & Africa Valsartan Sales Market Share by Type in 2020
Figure 65. Middle East & Africa Valsartan Sales Market Share by Application in 2020
Figure 66. Egypt Valsartan Revenue Growth 2016-2021 ($ Millions)
Figure 67. South Africa Valsartan Revenue Growth 2016-2021 ($ Millions)
Figure 68. Israel Valsartan Revenue Growth 2016-2021 ($ Millions)
Figure 69. Turkey Valsartan Revenue Growth 2016-2021 ($ Millions)
Figure 70. GCC Country Valsartan Revenue Growth 2016-2021 ($ Millions)
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
  • Global Pulmonary Arterial Hypertension (Pah) Medicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Pulmonary Arterial Hypertension (Pah) Medicine market: According to our latest research, the global Pulmonary Arterial Hypertension (Pah) Medicine market looks promising in the next 5 years. As of 2022, the global Pulmonary Arterial Hypertension (Pah) Medicine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to ......
  • Global Nifedipine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 102
    Market Overview of Global Nifedipine market: According to our latest research, the global Nifedipine market looks promising in the next 5 years. As of 2022, the global Nifedipine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nifedipine market, with a systematical de......
  • Global Amlodipine Besylate Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 115
    The Amlodipine Besylate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amlodipine Besylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profil......
  • Pulmonary Arterial Hypertension (PAH) Drugs - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 112
    The global Pulmonary Arterial Hypertension (PAH) Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pulmonary Arterial Hypertension (PAH) Drugs in various end use industries. The expanding demands from the Hospitals, Clinics and Other,, are propelling Pulmonary Arterial Hypertension (PAH) Drugs market. Inhalation, one of the segments analysed in this report, is projected to record % ......
  • Captopril API - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 100
    The global Captopril API market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Captopril API in various end use industries. The expanding demands from the Captopril Tablet, Compound Captopril Tablet and Captopril Injection,, are propelling Captopril API market. 98% Captopril API, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......
  • Telmisartan - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 107
    The global Telmisartan market size is expected to reach US$ 3631.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Telmisartan in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Telmisartan market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-Dried......
  • Global Ambrisentan Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 106
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Ambrisentan Market Research Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 132
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Amlodipine Besylate Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 133
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs